Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
48.67
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Sanofi-Aventis S.A. ADR
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
25
26
Next >
Regeneron-Sanofi's Dupixent Wins European Approval For Prurigo Nodularis
December 15, 2022
Via
Benzinga
These Biotech Stocks Are the Nasdaq's Big Wednesday Winners
December 14, 2022
Business wins are shining the spotlight on these two companies.
Via
The Motley Fool
Why Is Kymera Therapeutics (KYMR) Stock Up 20% Today?
December 14, 2022
KYMR stock traders are bidding up the share price today as Kymera Therapeutics teams up to take a skin condition treatment to the next phase.
Via
InvestorPlace
Kymera Therapeutics Stock Jumps After Positive Data From Atopic Dermatitis Trial
December 14, 2022
Via
Benzinga
Why Small Biotech Kymera Just Snagged Sanofi's Interest And Surged 28%
December 14, 2022
The company is working on protein degradation in cancer and inflammatory diseases.
Via
Investor's Business Daily
Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal
December 12, 2022
HZNP stock is up on news that Horizon Therapeutics is being bought by Amgen in a friendly deal that's positive for both companies.
Via
InvestorPlace
Amgen To Buy Rare Diseases Drugmaker Horizon Therapeutics In $28.3 Billion Deal
December 12, 2022
The deal comes a day after Sanofi dropped out of the bidding process.
Via
Investor's Business Daily
Broadcom-Vmware Deal Draws European Regulatory Attention, Rivian Pauses Mercedes-Partnered EV Van Plans For Europe, Credit Suisse Issued Loan On Suspicious Bills: Top Stories Monday, Dec. 12
December 12, 2022
Reuters Broadcom's Vmware Draws More Regulatory Attention, This Time From EU
Via
Benzinga
Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share
December 12, 2022
Via
Benzinga
Will This Potential Approval Be a Winner for Sanofi's Shareholders?
December 09, 2022
Sanofi and Regeneron's Dupixent moved closer to regulatory approval to treat another skin disease in the European Union.
Via
The Motley Fool
France Health Body Advises Unfavorable Opinion Regarding Valneva's COVID-19 Vaccine
December 08, 2022
Via
Benzinga
This Monster Dividend Stock Isn't Done Growing
December 08, 2022
Is another deal on the way for Johnson & Johnson?
Via
The Motley Fool
Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration
December 08, 2022
Via
Benzinga
Fusion Fuel (HTOO) Stock Is Up 11% on HUGE Deal News
December 07, 2022
Fusion Fuel (HTOO) stock is heading higher on Wednesday after the company secured a deal with the Portuguese government.
Via
InvestorPlace
Why Is TransCode Therapeutics (RNAZ) Stock Up 148% Today?
December 07, 2022
TransCode Therapeutics (RNAZ) stock is rallying higher on Wednesday after the company withdrew plans for a secondary offering.
Via
InvestorPlace
SNY Stock Alert: Why 1 Analyst Says Zantac Ruling Is ‘Best-Case Scenario’ for Drugmakers
December 07, 2022
Sanofi (SNY) stock is in the news as one analyst believes the latest court ruling is the "best-case scenario" for the drugmaker.
Via
InvestorPlace
Meta Criticized For Providing Extra Protection To Certain Users, Twitter HQ Bedrooms Under Regulatory Scrutiny, Juul Settles Over 5,000 Lawsuits: Top Stories Wednesday, Dec. 07
December 07, 2022
Benzinga
Via
Benzinga
Relief To Pfizer, Sanofi As US Dismisses Several Lawsuits Associated With Zantac
December 07, 2022
Via
Benzinga
These 3 Stocks Escaped Tuesday's Market Downdraft
December 06, 2022
Even a dour outlook for the broader stock market couldn't outweigh good news for these companies.
Via
The Motley Fool
Why GSK Plc And Sanofi SA Stock Are Shooting Higher
December 06, 2022
Shares of GSK plc (NYSE: GSK) and Sanofi SA (NASDAQ: SNY) are trading higher going into the close of Tuesday's session after the companies reportedly won a Zantac product liability lawsuit.
Via
Benzinga
Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, Sanofi
December 05, 2022
There are now two companies in the ring for a Horizon takeover.
Via
Investor's Business Daily
Stock Market Rally Fights At Key Level On Powell, Inflation Data, Jobs Report: Weekly Review
December 02, 2022
The S&P 500 is fighting for its 200-day, a critical level for the uptrend.
Via
Investor's Business Daily
If Sanofi Opted For Takeover Of Horizon Therapeutics, It Would Be In Cash
December 02, 2022
Via
Benzinga
Why Horizon Therapeutics Stock Is Skyrocketing Today
November 30, 2022
Three big drugmakers could be interested in acquiring Horizon.
Via
The Motley Fool
Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?
November 30, 2022
Horizon Therapeutics (HZNP) stock is rising higher on Wednesday following reports that the company is considering a buyout.
Via
InvestorPlace
Are Tech Layoffs Going to Be a Headache for Alexandria Real Estate Equities?
November 30, 2022
Tech layoffs are in the news, but life sciences companies seem to be doing better.
Via
The Motley Fool
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent
November 30, 2022
Via
Benzinga
iPhone Pro Shipments May Miss Consensus, Tesla Rival Charts Ambitious Expansion Plan In Mexico, Amazon Cloud Unit To Add More Employees: Top Stories Wednesday, Nov. 30
November 30, 2022
Reuters
Via
Benzinga
Horizon Therapeutics Shares Jump On Confirmation Of Takeover Talks With Several Large Companies
November 30, 2022
Via
Benzinga
Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, Sanofi
November 29, 2022
The three companies have until Jan. 10 to decide whether they want to buy Horizon.
Via
Investor's Business Daily
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
25
26
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.